Research Nester’s recent market research analysis on “Single-Cell Omics Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitors analysis and a detailed overview of the global single-cell omics market in terms of market segmentation by application, product, end user, and by region.
Growing Research on New Products to Promote Global Market Share of Single-Cell Omics
The global single-cell omics market is estimated to grow majorly on account of the new research and launch of cutting-edge technologies which is also driving more investment in the field. These are the primary factors boosting the industry size. The subject of single-cell omics is quickly expanding, driven by constant technological and methodological breakthroughs. These technical improvements entice researchers and increase demand for these novel products. For instance, SCIENION and Cellenion introduced CellenCHIP 384 for single-cell omics sample preparation as a crucial component in the new cellenCHIP 384. Moreover, the National Institutes of Health (NIH) recently awarded the Texas A&M University System a USD 1.19 million grant to investigate the profound linkages between genes, nutrition, and health.
Besides this, the rising demand for new cancer treatments and biologics is also expected to the demand for single-cell omics, thus expanding the market size. Single-cell omics are a valuable method for isolating cancer cells. Researchers can uncover unusual cell types that contribute to tumor growth, progression, and responsiveness to therapy by analyzing individual cancer cells. Moreover, based on the Food and Drug Administration, the Centre for Drug Evaluation and Research (CDER) authorized 37 novel pharmaceuticals as new therapeutic biological products through Biologics License Applications (BLAs) in 2022.
Some of the major growth factors and challenges that are associated with the growth of the global single-cell omics market are:
Growth Drivers:
· Surge in the New Cancer Cases in the World
· Manufacturing of New Technologies
Challenges:
The high cost of single-cell omics technique and there is no data and standards protocols that are to be followed during the research, these are some of the major factors anticipated to hamper the global market size of single-cell omics. The inexpensiveness and cost-effectiveness of single-cell omics technologies are still difficult to achieve for wider applications, particularly in resource-constrained settings or for small research institutes. Moreover, single-cell omics techniques involve intricate and complex workflows, requiring specialized equipment, protocols, and expertise. Technical complexity can pose challenges in terms of standardization, reproducibility, and data quality. Ensuring consistency and reliability across different laboratories and platforms remains a challenge, which can impact the widespread adoption and scalability of single-cell omics technologies.
Access our detailed report at:
https://www.researchnester.com/reports/single-cell-omics-market/5060
The global single-cell omics market is segmented into product, application, and end user. On the basis of end users, the market is fragmented into pharmaceutical & biotechnology companies, research organizations, and hospitals. The research organization segment will grow at the highest CAGR over the forecast time frame. The segment growth is credited to the higher influx of investment into the research facilities, which in turn is expected to the adoption of new technologies, equipping the facilities with new products and techniques and higher skilled workers. Furthermore, based on application, the single-cell omics market is further divided into immunology, neurology, oncology, and cell biology. Out of these three, the oncology segment is anticipated to accumulate a great market share by the end of 2035. Higher clinical trials of genomic cancer treatment and growing penetration of cancer cases are primarily responsible for the market’s growth.
In 2035, the market in Europe is also expected to show significant growth. Europe has a strong emphasis on scientific research and innovation, supported by substantial funding initiatives from both public and private sources. Funding agencies, such as European Research Council (ERC) and Horizon Europe, provide grants and support for research projects involving single-cell omics. The availability of research funding encourages scientists and institutions in Europe to invest in single-cell omics technologies.
This report also provides the existing competitive scenario of some of the key players of the global single-cell omics market which includes company profiling of 10x Genomics, Inc., Becton, Dickinson and Company (BD), CELLENION, PerkinElmer Inc., ANGLE plc, Illumina, Inc., Bio-Rad Laboratories, Inc., Mission Bio Inc., Standard BioTools Inc. and Ultima Genomics, Inc.
Request Report Sample@
https://www.researchnester.com/sample-request-5060
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919